Close Menu

UNC Chapel Hill

This article was originally posted March 29.
The annual meeting of the American College of Cardiology held last week in Chicago featured a number of pharmacogenomically guided studies related to treatments for cardiovascular disease.

This article has been updated to clarify funding sources for the investigators who won the awards.
By a GenomeWeb staff reporter

By Doug Macron
About a year and a half after its founding, siRNA delivery firm Qualiber has secured a $30,000 low-interest loan from the North Carolina Biotechnology Center to help it with non-scientific startup activities.

Name:
Scott Hammond
Position:
Associate professor, cell and developmental biology, University of North Carolina, Chapel Hill

In a recent commentary in Genetics in Medicine, Jonathan Berg and co-authors outlined a binning scheme for classifying variants that are found incidentally during whole-genome sequencing in order to decide which ones to report back to patients.

Greece's Golden Helix Institute is the new hub for Eastern Europe in UNC's PGENI, an international initiative to make genetic risk data available and affordable by genotyping the populations of various countries.

Biosigma, Canon, Advanced Liquid Logic, Duke University, Qiagen, and others win US patents.

Bioclassifier has licensed to NanoString the rights to develop in vitro diagnostic and research products based on the so-called PAM50 gene signature and NanoString's nCounter platform. Meantime, ARUP Laboratories will next month launch a laboratory-developed qPCR test based on the signature.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.